Atkinson, SR;
Way, MJ;
McQuillin, A;
Morgan, MY;
Thursz, MR;
(2017)
Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis.
Journal of Hepatology
, 67
(1)
pp. 120-127.
10.1016/j.jhep.2017.01.018.
Preview |
Text
1-s2.0-S016882781730051X-main.pdf - Accepted Version Download (1MB) | Preview |
Abstract
BACKGROUND & AIMS: Carriage of rs738409:G in PNPLA3 is associated with an increased risk of developing alcohol-related cirrhosis and has a significant negative effect on survival. Short-term mortality in patients with severe alcoholic hepatitis is high; drinking behaviour is a major determinant of outcome in survivors. The aim of this study was to determine whether carriage of rs738409:G has an additional detrimental effect on survival in this patient group. METHODS: Genotyping was undertaken in 898 cases with severe alcoholic hepatitis, recruited through the UK Steroids or Pentoxifylline for Alcoholic Hepatitis (STOPAH) trial, and 1,188 white British/Irish alcohol dependent controls with no liver injury recruited via University College London. Subsequent drinking behaviour was classified, in cases surviving ⩾90 days, as abstinent or drinking. The relationship between rs738409 genotype, drinking behaviour and survival was explored. RESULTS: The frequency of rs738409:G was significantly higher in cases than controls (29.5% vs. 18.9%; p=2.15x10(-15); OR 1.80 [95%CI 1.55-2.08]). Case-mortality at days 28, 90 and 450 was, 16%, 25% and 41% respectively. There was no association between rs738409:G and 28-day mortality. Mortality in the period day 90-450 was higher in survivors who subsequently resumed drinking (Hazard Ratio [HR] 2.77, 95% Confidence Interval [CI] 1.79-4.29; p<0.0001) and individuals homozygous for rs738409:G (HR 1.69, 95% CI 1.02-2.81, p=0.04). CONCLUSION: Homozygosity for rs738409:G in PNPLA3 confers significant additional risk of medium-term mortality in patients with severe alcoholic hepatitis. Rs738409 genotype may be taken into account when considering treatment options in these patients. LAY SUMMARY: Individuals misusing alcohol who carry a particular variant of the gene PNPLA3 are more at risk of developing severe alcoholic hepatitis, a condition with a poor chance of survival. The longer-term outcome in people with this condition who survive the initial illness is strongly influenced by their ability to remain abstinent from alcohol. However, carriers of this gene variant are less likely to survive even if they are able to stop drinking completely. Knowing if someone carries this gene variant could influence the way in which they are managed.
Type: | Article |
---|---|
Title: | Homozygosity for rs738409:G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis. |
Location: | Netherlands |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1016/j.jhep.2017.01.018 |
Publisher version: | http://dx.doi.org/10.1016/j.jhep.2017.01.018 |
Language: | English |
Additional information: | © 2016. This manuscript version is published under a Creative Commons Attribution Non-commercial Non-derivative 4.0 International licence (CC BY-NC-ND 4.0). This licence allows you to share, copy, distribute and transmit the work for personal and non-commercial use providing author and publisher attribution is clearly stated. Further details about CC BY licences are available at http://creativecommons.org/licenses/by/4.0. Access may be initially restricted by the publisher. |
Keywords: | Alcohol dependence, Alcohol-related cirrhosis, Alcoholic hepatitis, Genetic polymorphism, PNPLA3, Prednisolone, prognostic scores, Risk allele, Survival |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Division of Psychiatry UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inst for Liver and Digestive Hlth |
URI: | https://discovery.ucl.ac.uk/id/eprint/1540355 |
Archive Staff Only
View Item |